Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenocarcinoma Therapy
Researchers from University of Padova detail new studies and findings in the area of adenocarcinoma therapy
March 2nd, 2008
New research, 'The ability of coumarin-, flavanon- and flavonol-analogues of flavone acetic acid to stimulate human monocytes,' is the subject of a report. "Flavone acetic acid (FAA) is a semi-synthetic flavonoid characterised by potent immune-modulatory and antivascular activity on mice but not in humans. Previously, the synthesis and cytotoxic activity on a human adenocarcinoma cell line of coumarin-, flavanon-and flavonol-derivatives of FAA were described," scientists in Padova, Italy report. "These analogues were able to induce the reduction of lysosomal neutral red uptake at 5 x 10(-5) M concentration and some of them were more effective than FAA. Some of these...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-02)
|
